Company Overview

• Hepa Thera, headquartered in Shanghai, is a biotech company incubated by Fosun Pharma through its strategic corporate venture capital arm—the Fosun Health Capital New Drug Fund. Following a Flagship Pioneering-style innovation model, the fund has established a robust portfolio of cutting-edge biotech ventures, with Hepa Thera at the forefront of its commitment to pioneering therapeutic breakthroughs for liver diseases.

• At Hepa Thera, We envision a world free from liver disease, especially the hepatitis B and D. We are developing innovative therapies that are designed to address the complex and huge unmet needs of people with such liver diseases of Hepatitis B and D, MASH, and Fibrosis etc.al.

Backed by Vision, Built for Innovation